318 related articles for article (PubMed ID: 24302991)
1. miR-146a enhances the oncogenicity of oral carcinoma by concomitant targeting of the IRAK1, TRAF6 and NUMB genes.
Hung PS; Liu CJ; Chou CS; Kao SY; Yang CC; Chang KW; Chiu TH; Lin SC
PLoS One; 2013; 8(11):e79926. PubMed ID: 24302991
[TBL] [Abstract][Full Text] [Related]
2. Functional diversity of miR-146a-5p and TRAF6 in normal and oral cancer cells.
Min SK; Jung SY; Kang HK; Park SA; Lee JH; Kim MJ; Min BM
Int J Oncol; 2017 Nov; 51(5):1541-1552. PubMed ID: 29048658
[TBL] [Abstract][Full Text] [Related]
3. miR-146a promotes Borna disease virus 1 replication through IRAK1/TRAF6/NF-κB signaling pathway.
Zhang X; Guo Y; Xu X; Tang T; Sun L; Wang H; Zhou W; Fang L; Li Q; Xie P
Virus Res; 2019 Oct; 271():197671. PubMed ID: 31330207
[TBL] [Abstract][Full Text] [Related]
4. miR-146a promotes cervical cancer cell viability via targeting IRAK1 and TRAF6.
Hu Q; Song J; Ding B; Cui Y; Liang J; Han S
Oncol Rep; 2018 Jun; 39(6):3015-3024. PubMed ID: 29693168
[TBL] [Abstract][Full Text] [Related]
5. Dexmedetomidine exerts cardioprotective effect through miR-146a-3p targeting IRAK1 and TRAF6 via inhibition of the NF-κB pathway.
He L; Wang Z; Zhou R; Xiong W; Yang Y; Song N; Qian J
Biomed Pharmacother; 2021 Jan; 133():110993. PubMed ID: 33220608
[TBL] [Abstract][Full Text] [Related]
6. Up-regulation of miR-187 modulates the advances of oral carcinoma by targeting BARX2 tumor suppressor.
Lin SC; Kao SY; Chang JC; Liu YC; Yu EH; Tseng SH; Liu CJ; Chang KW
Oncotarget; 2016 Sep; 7(38):61355-61365. PubMed ID: 27542258
[TBL] [Abstract][Full Text] [Related]
7.
Chou CH; Chiang CF; Yang CC; Liu YC; Chang SR; Chang KW; Lin SC
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769160
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-146a and microRNA-146b regulate human dendritic cell apoptosis and cytokine production by targeting TRAF6 and IRAK1 proteins.
Park H; Huang X; Lu C; Cairo MS; Zhou X
J Biol Chem; 2015 Jan; 290(5):2831-41. PubMed ID: 25505246
[TBL] [Abstract][Full Text] [Related]
9. G2013 modulates TLR4 signaling pathway in IRAK-1 and TARF-6 dependent and miR-146a independent manner.
Hajivalili M; Pourgholi F; Majidi J; Aghebati-Maleki L; Movassaghpour AA; Samadi Kafil H; Mirshafiey A; Yousefi M
Cell Mol Biol (Noisy-le-grand); 2016 Apr; 62(4):1-5. PubMed ID: 27188726
[TBL] [Abstract][Full Text] [Related]
10. miR-146a ameliorates liver ischemia/reperfusion injury by suppressing IRAK1 and TRAF6.
Jiang W; Kong L; Ni Q; Lu Y; Ding W; Liu G; Pu L; Tang W; Kong L
PLoS One; 2014; 9(7):e101530. PubMed ID: 24987958
[TBL] [Abstract][Full Text] [Related]
11. Association between the rs2910164 polymorphism in pre-mir-146a and oral carcinoma progression.
Hung PS; Chang KW; Kao SY; Chu TH; Liu CJ; Lin SC
Oral Oncol; 2012 May; 48(5):404-8. PubMed ID: 22182931
[TBL] [Abstract][Full Text] [Related]
12. Regulatory effects of miR-146a/b on the function of endothelial progenitor cells in acute ischemic stroke in mice.
Su ZF; Sun ZW; Zhang Y; Wang S; Yu QG; Wu ZB
Kaohsiung J Med Sci; 2017 Aug; 33(8):369-378. PubMed ID: 28811005
[TBL] [Abstract][Full Text] [Related]
13. miR-146a regulates inflammatory cytokine production in Porphyromonas gingivalis lipopolysaccharide-stimulated B cells by targeting IRAK1 but not TRAF6.
Jiang S; Hu Y; Deng S; Deng J; Yu X; Huang G; Kawai T; Han X
Biochim Biophys Acta Mol Basis Dis; 2018 Mar; 1864(3):925-933. PubMed ID: 29288795
[TBL] [Abstract][Full Text] [Related]
14. miR-146a promotes proliferation, invasion, and epithelial-to-mesenchymal transition in oral squamous carcinoma cells.
Wang F; Ye LJ; Wang FJ; Liu HF; Wang XL
Environ Toxicol; 2020 Oct; 35(10):1050-1057. PubMed ID: 32469461
[TBL] [Abstract][Full Text] [Related]
15. Lipopolysaccharide induces the migration of human dental pulp cells by up-regulating miR-146a.
Wang MC; Hung PS; Tu HF; Shih WY; Li WC; Chang KW
J Endod; 2012 Dec; 38(12):1598-603. PubMed ID: 23146644
[TBL] [Abstract][Full Text] [Related]
16. MiR-338 suppresses the growth and metastasis of OSCC cells by targeting NRP1.
Liu C; Wang Z; Wang Y; Gu W
Mol Cell Biochem; 2015 Jan; 398(1-2):115-22. PubMed ID: 25204970
[TBL] [Abstract][Full Text] [Related]
17. Passenger strand miRNA miR-31* regulates the phenotypes of oral cancer cells by targeting RhoA.
Chang KW; Kao SY; Wu YH; Tsai MM; Tu HF; Liu CJ; Lui MT; Lin SC
Oral Oncol; 2013 Jan; 49(1):27-33. PubMed ID: 22854067
[TBL] [Abstract][Full Text] [Related]
18. The role of miR-146a on NF-κB expression level in human umbilical vein endothelial cells under hyperglycemic condition.
Kamali K; Korjan ES; Eftekhar E; Malekzadeh K; Soufi FG
Bratisl Lek Listy; 2016; 117(7):376-80. PubMed ID: 27546538
[TBL] [Abstract][Full Text] [Related]
19. Chronic constriction injury-induced microRNA-146a-5p alleviates neuropathic pain through suppression of IRAK1/TRAF6 signaling pathway.
Wang Z; Liu F; Wei M; Qiu Y; Ma C; Shen L; Huang Y
J Neuroinflammation; 2018 Jun; 15(1):179. PubMed ID: 29885668
[TBL] [Abstract][Full Text] [Related]
20. Increased microRNA-146a/b, TRAF6 gene and decreased IRAK1 gene expressions in the peripheral mononuclear cells of patients with Sjögren's syndrome.
Zilahi E; Tarr T; Papp G; Griger Z; Sipka S; Zeher M
Immunol Lett; 2012 Jan; 141(2):165-8. PubMed ID: 22033216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
